Search Results

You are looking at 1-10 of 21

Management of Patients With Cardiovascular Implantable Electronic Devices in Dental, Oral, and Maxillofacial Surgery
James TomDDS, MS
Article Category: Research Article
Volume/Issue: Volume 63: Issue 2
Online Publication Date: Jan 01, 2016
DOI: 10.2344/0003-3006-63.2.95
Page Range: 95 – 104

interference (EMI) and electromagnetic disturbance from electrosurgery/electrocautery devices, apex locators, lasers, electric handpieces, radiation, and other electronic sources. Additionally, vasoactive drugs, such as epinephrine-containing local anesthetics and other sympathomimetics that may be administered during anesthetic management, may have significant effects upon patients who suffer from tachyarrhythmias. Several guidelines have already been promulgated for surgeons and anesthesia providers in the medical field, and parallel treatment decisions can also be

Download PDF
Figure 1. ; Paced rhythm with pacer “spike.”
James Tom
<bold>Figure 1.</bold>
 
Figure 1.

Paced rhythm with pacer “spike.”


James Tom
<bold>Figure 2.</bold>
 
Figure 2.

Medtronic MRI-compitable pacemaker.


James Tom
<bold>Figure 3.</bold>
 
Figure 3.

Typical ICD and right atrial and right ventricular lead placement.


James Tom
<bold>Figure 4.</bold>
 
Figure 4.

Typical 90-gauss “doughnut” magnet.


Article Category: Other
Volume/Issue: Volume 63: Issue 4
Online Publication Date: Jan 01, 2016
Page Range: 218 – 218

alveolar nerve block, 3 Prediabetes, 208 Preinjection, 55 Propofol, 67, 80, 116, 147, 175, 185 Rabbit, 17 Radiographs, 95 Recovery profile, 175 Refrigerant, 55 Remifentanil, 116 Ropivacaine, 71 Salivary secretion, 185 Sedation, 67 Sensing, 95 Sevoflurane, 42, 175 Sex, 67 Solubility, 42 Tachyarrhythmias, 95 Takayasu arteritis, 31 Tetany, 25 Tooth extraction, 156 Topical agents, 55 Type 2 diabetes, 208

Tsuyoshi HoshiDDS,
Takashi SuzukiMD, PhD,
Masayuki SomeiMD, PhD,
Takehiko IijimaDDS, PhD, and
Yuka KuriharaDDS
Article Category: Case Report
Volume/Issue: Volume 65: Issue 4
Online Publication Date: Jan 01, 2018
Page Range: 259 – 260

. Effects of nasal application of an epinephrine and lidocaine mixture on the hemodynamics and nasal mucosa in oral and maxillofacial surgery . J Oral Maxillofac Surg . 2008 ; 66 : 2226 – 2232 . 4 Plosker GL. Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias . Drugs . 2013 ; 73 : 959 – 977 . 5 Krebs MJ

Mark A. SaxenDDS, PhD
Article Category: Research Article
Volume/Issue: Volume 67: Issue 2
Online Publication Date: Jul 06, 2020
Page Range: 121 – 123

scientific literature and analysis of expert opinion, clinical feasibility data, open forum commentary, and consensus surveys. This updated advisory focuses on the perioperative management of the patient who has a pre-existing cardiac implantable electronic device (CIED) for the treatment of a bradyarrhythmia, tachyarrhythmia, or heart failure. It applies to all patients with a CIED receiving general or regional anesthesia, sedation, or monitored anesthesia care. Both inpatient and outpatient procedures are addressed by this update. A focused preoperative

Toshiyuki KishimotoDDS, PhD,
Yoshiaki TakitaniDDS, PhD,
Tomoka Ichikawa,
Kaho ShiraishiDDS,
Hiroki YamadaDDS,
Shoko OyaDDS,
Makoto KumeMD, PhD, and
Satoru SakuraiDDS, PhD
Article Category: Case Report
Volume/Issue: Volume 70: Issue 2
Online Publication Date: Jun 28, 2023
Page Range: 70 – 74

performed for disuse syndrome, and was later discharged without sequelae. DISCUSSION Pilsicainide is an antiarrhythmic drug classified as Vaughan-Williams class Ic. Because it selectively blocks Na + channels and does not affect K + and Ca 2+ channels, it inhibits conduction to the atrial muscles, the conduction system tissues below the His bundle, and the ventricular muscles. 14 Pilsicainide has arrhythmogenic and negative inotropic effects and is indicated for ventricular and supraventricular tachyarrhythmias that are not associated with

Mark A. SaxenDDS, PhD
Article Category: Research Article
Volume/Issue: Volume 70: Issue 4
Online Publication Date: Jan 15, 2024
Page Range: 206 – 208

an unknown period of time. Two of these cases presented somnolence and 1 with a seizure. Additional signs and symptoms reported upon presentation included twitches, tachyarrhythmia, or perioral tingling. Comment: The authors of this article note that the maximum safe dose of lidocaine that can be used for airway topicalization is unknown. The maximum recommended dose varies across nations, with most ranging between 3 and 5 mg/kg. A lack of consensus also exists for the body weight type that should be used for calculations. The Difficult Airway Society